Eric Dobmeier, President, CEO at CHINOOK THERAPEUTICS, INC. (KDNY), sold 40,376 shares at $24.68 ($993K) on 2023-01-31, disclosed to the SEC on 2023-02-01.
Open-market sale of $993k KDNY by President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.54 | 25,000 | $614K | 61.8% |
| 2 | $24.68 | 7,688 | $190K | 19.1% |
| 3 | $24.68 | 7,688 | $190K | 19.1% |
| Total | $24.59 avg | 40,376 | $993K | 100% |
| Filing → |
| KDNY | SELL | 2023-02-15 | $385K | — | Filing → |
| KDNY | SELL | 2022-12-02 | $669K | — | Filing → |
| KDNY | BUY | 2022-05-27 | $65K | — | Filing → |